End of Project Evaluation of the Market Entry Grant to the Diagnostics for the Real Workd on SAMBA Titled: “Providing Access to Early Infant Diagnosis and Viral Load Monitoring by SAMBA – a Point-of-Care Nucleic Acid Detection System”

End of Project Evaluation of the Market Entry Grant to the Diagnostics for the Real Workd on SAMBA Titled: “Providing Access to Early Infant Diagnosis and Viral Load Monitoring by SAMBA – a Point-of-Care Nucleic Acid Detection System”

Abstract

Cambridge Economic Policy Associates (CEPA) was appointed by Unitaid to conduct an end of grant evaluation of the market entry grant to the Diagnostics for the Real World (DRW) titled “Providing Access to Early Infant Diagnosis (EID) and Viral Load (VL) Monitoring through Simple Amplification-Based Assay device (SAMBA), a Point-of-Care (POC) Nucleic Acid Detection System”. This document provides a summary of our evaluation findings, conclusions and recommendations. It includes a background to the grant (Section 2); the evaluation objectives and methods (Section 3); a framework for assessing market entry progress of the grant (Section 4); the evaluation analysis and key findings (Sections 5) and overall conclusions, lessons learnt and recommendations (Section 6).